SGLT2 transcriptomic expression atlas supports a kidney-centric role for empagliflozin's benefits in heart failure
Mourad, O.; Vohra, S.; Nunes, S. S.
10.1101/2023.07.03.547550 bioRxivShow abstract
Sodium-glucose cotransporter 2 inhibitors (SGLT2i), such as empagliflozin, have shown remarkable benefits in reducing cardiovascular events and mortality in patients with heart failure (HF) irrespective of diabetic status. Because of the magnitude of the benefits and broad application in both HF with reduced and preserved ejection fraction (EF), there have been concerted efforts to identify a mechanism for the observed benefits. One hypothesis is that SGLT2i act directly on the heart. Given empagliflozins high specificity to SGLT2, we reasoned that SGLT2 expression would be a requirement for cells to respond to treatment. Here, we present a comprehensive transcriptomic analysis of SLC5A2, which encodes SGLT2, at the single cell level in multiple datasets, confirming SLC5A2 expression in a subset of kidney epithelial cells but no meaningful expression in other cell types. This was true irrespective of developmental stage, disease state, sequencing method or depth, and species. Our findings support a kidney-centric role for the cardiovascular improvements reported in patients treated with SGLT2i.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Control of cytokinesis by β-adrenergic receptors indicates an approach for regulating cardiomyocyte endowment 92%
- Dynamic Loading of Human Engineered Heart Tissue Enhances Contractile Function and Drives Desmosome-linked Disease Phenotype 89%
- Augmentation of DNA exonuclease TREX1 in macrophages as a therapy for cardiac ischemic injury 89%
Similar papers in this journal
- Interleukin-1β Drives Disease Progression in Arrhythmogenic Cardiomyopathy 94%
- Apolipoprotein M attenuates anthracycline cardiotoxicity and lysosomal injury 94%
- Intermittent Fasting Activates AMP-Kinase to Restructure Right Ventricular Lipid Metabolism and Microtubules in Two Rodent Models of Pulmonary Arterial Hypertension 93%
Similar papers in this journal
- Deciphering human heart failure with preserved ejection fraction (HFpEF) at single cell resolution 93%
- Genome wide association analysis in dilated cardiomyopathy reveals two new key players in systolic heart failure on chromosome 3p25.1 and 22q11.23 93%
- Endocardial/endothelial angiocrines regulate cardiomyocyte development and maturation and induce features of ventricular non-compaction 92%
Similar papers in this journal
- Human induced pluripotent stem cell-derived cardiomyocytes to study inflammation-induced diastolic dysfunction 95%
- Ryanodine receptor 2 inhibition reduces dispersion of cardiac repolarization, improves contractile function and prevents sudden arrhythmic death in failing hearts 94%
- SIRT2 inhibition protects against cardiac hypertrophy and heart failure 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.